APOLIPOPROTEIN B IS RELATED TO METABOLIC SYNDROME INDEPENDENTLY OF LDL-CHOLESTEROL IN PATIENTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Lim, Y. -H. [1 ]
Yoo, S. Y. [1 ]
Chin, S. O. [1 ]
Lee, S. A. [1 ]
Koh, G. P. [1 ]
机构：
[1] Jeju Natl Univ Hosp, Internal Med, Jeju, South Korea
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70317-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO022
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [31] Efficacy of atorvastatin for achieving cholesterol targets after LDL-cholesterol based dose selection in patients with type 2 diabetes
    Carlos Ferrer-Garcia, Juan
    Sanchez-Ballester, Eva
    Albalat-Galera, Raquel
    Berzosa-Sanchez, Miguel
    Herrera-Ballester, Agustin
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, 13 (03) : 183 - 188
  • [32] The effects of statin and fibrate on lowering small dense LDL-cholesterol in hyperlipidemic patients with type 2 diabetes
    Tokuno, Anna
    Hirano, Tsutomu
    Hayashi, Toshiyuki
    Mori, Yusaku
    Yamamoto, Takeshi
    Nagashima, Masaharu
    Shiraishi, Yuji
    Ito, Yasuki
    Adachi, Mitsuru
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2007, 14 (03) : 128 - 132
  • [33] APOLIPOPROTEIN B VERSUS LDL-CHOLESTEROL: ASSOCIATION WITH OTHER RISK FACTORS FOR ATHEROSCLEROSIS
    Vaverkova, H.
    Karasek, D.
    Novotny, D.
    Jackuliakova, D.
    Lukes, J.
    Frohlich, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [34] Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis
    Vaverkova, Helena
    Karasek, David
    Novotny, Dalibor
    Jackuliakova, Dagmar
    Lukes, Jiri
    Halenka, Milan
    Frohlich, Jiri
    CLINICAL BIOCHEMISTRY, 2009, 42 (12) : 1246 - 1251
  • [35] LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model
    Laura Inglin
    Piia Lavikainen
    Kari Jalkanen
    Tiina Laatikainen
    Scientific Reports, 11
  • [36] Clinical Significance and Potential Mechanism of Discordance Between Apolipoprotein B and LDL-Cholesterol
    Onat, Altan
    Altay, Servet
    Karadeniz, Yusuf
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (25) : 3023 - 3024
  • [37] Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus
    Russo, Giuseppina
    Pintaudi, Basilio
    Giorda, Carlo
    Lucisano, Giuseppe
    Nicolucci, Antonio
    Cristofaro, Maria Rosaria
    Suraci, Concetta
    Mulas, Maria Franca
    Napoli, Angela
    Rossi, Maria Chiara
    Manicardi, Valeria
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [38] Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis
    Kawamoto, R
    Tomita, H
    Oka, Y
    Kodama, A
    Kamitani, A
    INTERNAL MEDICINE, 2005, 44 (12) : 1232 - 1238
  • [39] The clinical usefulness of direct LDL-cholesterol measurements in type 2 diabetes mellitus.
    Wong, M
    Sethi, S
    Lim, P
    Tee, A
    Aw, T
    CLINICAL CHEMISTRY, 2000, 46 (06) : A100 - A100
  • [40] THE TOTAL APOLIPOPROTEIN-B LDL-CHOLESTEROL RATIO DOES NOT PREDICT LDL PARTICLE-SIZE
    TALLIS, GA
    SHEPHARD, MDS
    SOBECKI, S
    WHITING, MJ
    CLINICA CHIMICA ACTA, 1995, 240 (01) : 63 - 73
12345